Gary S. Gilkeson

Gary S. Gilkeson

Rheumatology

2060 Sam Rittenberg Blvd
2nd Floor
Charleston, SC 29407

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 116 publications

A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity.

A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity.

Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity.

Journal: Lupus science & medicine

Published: July 21, 2025

Advancing MSC therapy: The next generation of potent mesenchymal stromal cells for systemic autoimmune rheumatic diseases.

Advancing MSC therapy: The next generation of potent mesenchymal stromal cells for systemic autoimmune rheumatic diseases.

Journal: Best practice & research. Clinical haematology

Published: April 01, 2025

Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.

Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.

Journal: Cytotherapy

Published: March 26, 2025

Racial Differences in Plasma Microbial Translocation and Plasma Microbiome, Implications in Systemic Lupus Erythematosus Disease Pathogenesis.

Racial Differences in Plasma Microbial Translocation and Plasma Microbiome, Implications in Systemic Lupus Erythematosus Disease Pathogenesis.

Journal: ACR open rheumatology

Published: October 06, 2023

COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.

COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.

Journal: Journal of autoimmunity

Published: June 24, 2022

Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus.

Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: May 13, 2022

Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.

Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.

Journal: Journal of autoimmunity

Published: April 12, 2022

Formative research to promote lupus awareness and early screening at Historically Black College and University (HBCU) communities in South Carolina.

Formative research to promote lupus awareness and early screening at Historically Black College and University (HBCU) communities in South Carolina.

Journal: BMC rheumatology

Published: April 08, 2022

Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis.

Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis.

Journal: Clinical epigenetics

Published: April 06, 2022

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.

Journal: Lupus science & medicine

Published: April 04, 2022

Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.

Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.

Journal: Frontiers in immunology

Published: January 30, 2022

Showing 1-12 of 116

Last Updated: 09/26/2026